Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).

The investigators are doing this study to find out if a new kind of breast imaging (called upright dedicated breast CT or UBCT) can help doctors to see the small structures in breast tissue more clearly in 3-D and without overlap. The breast imaging device that will be used in this study (UBCT) is not FDA-approved, so this is a research study. The machine has been designed to remove mammography-like breast compression and use radiation dose comparable to mammography. The breast CT device will take multiple x-ray pictures of the subjects breast in approximately 20 seconds and create a 3-D image of the breast. It does not compress or squish the breast like a mammogram.

NCT Number	NCT07705100
Lead Sponsor	University of Arizona Collaborators: National Cancer Institute (NCI)
Conditions	Breast Cancer Detection
Enrollment	50 participants
Start Date	2026-08-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-27